Wednesday 03 Apr 2019 Pharmacy Daily Wednesday 3rd April 2019 t 1300 799 220 w www.pharmacydaily.com.au page 1 Today’s issue of PD Pharmacy Daily today has three pages of news including our weekly Health & Beauty feature plus the MIMS Monthly Update. Cutting-edge blister pack dispensing robot for DAA’s 25 to 40 packs per hour LEARN MORE Alpaca Automation COMPACT. FAST. ACCURATE. Perx Health App Referral Program Medication adherence made easier Find out more + Faster Nurofen RECKITT Benckiser is launching a fast-acng ibuprofen-lysine formulaon, Nurofen Quickzorb, this month. The combinaon of ibuprofen and lysine has been shown to absorb into the bloodstream quicker than ibuprofen alone. Cancer ad fines cut ADVERTISING including claims a paent was successfully treated for cancer using Chinese medicine, were not significant enough to warrant an inial $45,000 fine, a Sydney court has ruled. NSW-based Chinese medicine praconer, Qi Xin Chen, has been ordered to pay a fracon ($7,200) of the fine imposed on him for false adversing, aſter appealing the severity of the punishment. On 31 Oct 2018 Chen, who owns the Australian Natural Medicine Centre in Gladesville, NSW, was found to have published false misleading or decepve arcles on his company’s websites about the treatment of cancer. He was also found to have breached the Health Praconer Naonal Law by using tesmonials in his adversing, which would have created an unreasonable expectaon of beneficial treatment, including one tesmonial claiming that a paent had been cured of cancer using Chinese medicine. On 20 Nov, Chen filed a noce of appeal on the ground that the “penalty was too severe”. On 27 Mar, the District Court of NSW found the “unlawful use of tesmonials was at the lower end of the scale and other unlawful adversing was mid-range or below”. Budget 2019 pro pharmacy THE Australian pharmacy sector has generally welcomed last night’s Federal Budget, with a range of measures set to support the industry including an extension of the Administraon, Handling and Infrastructure (AHI) fee. $215 million has been provided over three years from 2020-21 to provide addional remuneraon to community pharmacies through increased AHI payments on all PBS scripts, which has been partly funded by reallocang money from Sixth Community Pharmacy Agreement professional programs. The Budget also provided $15 million over three years for addional Community Service Obligaon payments to pharmacy wholesalers, as well as $15 million in 2018-19 to promote quality use of medicines by paents through medicaon management programs in community pharmacy. Pricing arrangements for high cost medicines will also be aligned between community pharmacy and hospital, while $7.2 million has been provided for a “take home naloxone” program to help reduce deaths caused by opioids. Pharmacy Guild of Australia Naonal President, George Tambassis, also noted previous announcements about shortening the PBS payment cycles for pharmacies to help cashflow. Measures to assist small businesses included increasing the instant asset write-off threshold to $30,000 as well as expanding its accessibility to businesses turning over up to $50 million. The Budget also included $331 million for new and amended PBS lisngs, as part of $40 billion in the forward esmates for “life-saving and life-changing medicines”. Pharmaceucal Society of Australia Naonal President, Chris Freeman, welcomed the Budget but said more was needed for pharmacy. “Leading into the next Community Pharmacy Agreement, we would expect at least the same level of investment in community pharmacy and pharmacists to improve accessibility of care and health outcomes,” he said. “In a budget that has now returned to surplus...we need to have investment in pharmacy and pharmacists across sectors to improve the health of Australians”. The Australian Self-Medicaon Industry called for more to be done on health literacy and increasing access to medicines, while Medicines Australia CEO, Elizabeth de Somer, welcomed the Government’s “commitment to an uncapped PBS” through lisng all posive PBAC recommendaons. She said the fact that no new saving measures were imposed in the Budget was a reminder of the value of MA’s Strategic Agreement with the Government. Society of Hospital Pharmacists of Australia CEO, Krisn Michaels, welcomed the budget’s focus on “embedded pharmacy posions in aged care, investment in equal access to new medicines and improvements to hospital infrastructure”.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Wednesday 03 Apr 2019
Pharmacy Daily Wednesday 3rd April 2019 t 1300 799 220 w www.pharmacydaily.com.au page 1
Today’s issue of PDPharmacy Daily today
has three pages of news including our weekly Health & Beauty feature plus the MIMS Monthly Update.
RENEWAL DUE
www.pdl.org.au
use your member login to get started
C
M
Y
CM
MY
CY
CMY
K
Cutting-edge blister pack dispensing robot for DAA’s 25 to 40 packs per hour
LEARN MORE
Alpaca Automation
COMPACT.FAST. ACCURATE.
Perx Health App Referral ProgramMedication adherence made easier
Find out more +
Faster NurofenRECKITT Benckiser is launching
a fast-acting ibuprofen-lysine formulation, Nurofen Quickzorb, this month.
The combination of ibuprofen and lysine has been shown to absorb into the bloodstream quicker than ibuprofen alone. Cancer ad fines cut
ADVERTISING including claims a patient was successfully treated for cancer using Chinese medicine, were not significant enough to warrant an initial $45,000 fine, a Sydney court has ruled.
NSW-based Chinese medicine practitioner, Qi Xin Chen, has been ordered to pay a fraction ($7,200) of the fine imposed on him for false advertising, after appealing the severity of the punishment.
On 31 Oct 2018 Chen, who owns the Australian Natural Medicine Centre in Gladesville, NSW, was found to have published false misleading or deceptive articles on his company’s websites about the treatment of cancer.
He was also found to have breached the Health Practitioner National Law by using testimonials in his advertising, which would have created an unreasonable expectation of beneficial treatment, including one testimonial claiming that a patient had been cured of cancer using Chinese medicine.
On 20 Nov, Chen filed a notice of appeal on the ground that the “penalty was too severe”.
On 27 Mar, the District Court of NSW found the “unlawful use of testimonials was at the lower end of the scale and other unlawful advertising was mid-range or below”.
Budget 2019 pro pharmacyTHE Australian pharmacy sector
has generally welcomed last night’s Federal Budget, with a range of measures set to support the industry including an extension of the Administration, Handling and Infrastructure (AHI) fee.
$215 million has been provided over three years from 2020-21 to provide additional remuneration to community pharmacies through increased AHI payments on all PBS scripts, which has been partly funded by reallocating money from Sixth Community Pharmacy Agreement professional programs.
The Budget also provided $15 million over three years for additional Community Service Obligation payments to pharmacy wholesalers, as well as $15 million in 2018-19 to promote quality use of medicines by patients through medication management programs in community pharmacy.
Pricing arrangements for high cost medicines will also be aligned between community pharmacy and hospital, while $7.2 million has been provided for a “take home naloxone” program to help reduce deaths caused by opioids.
Pharmacy Guild of Australia National President, George Tambassis, also noted previous announcements about shortening the PBS payment cycles for pharmacies to help cashflow.
Measures to assist small businesses included increasing the instant asset write-off threshold to $30,000 as well as expanding its accessibility to businesses turning over up to $50 million.
The Budget also included $331 million for new and amended PBS listings, as part of $40 billion in the forward estimates for “life-saving and life-changing medicines”.
Pharmaceutical Society of Australia National President, Chris Freeman, welcomed the Budget but said more was needed for pharmacy.
“Leading into the next Community Pharmacy Agreement, we would expect at least the same level of investment in community pharmacy and pharmacists to improve accessibility of care and health outcomes,” he said.
“In a budget that has now returned to surplus...we need to have investment in pharmacy and pharmacists across sectors to improve the health of Australians”.
The Australian Self-Medication Industry called for more to be done on health literacy and increasing access to medicines, while Medicines Australia CEO, Elizabeth de Somer, welcomed the Government’s “commitment to an uncapped PBS” through listing all positive PBAC recommendations.
She said the fact that no new saving measures were imposed in the Budget was a reminder of the value of MA’s Strategic Agreement with the Government.
Society of Hospital Pharmacists of Australia CEO, Kristin Michaels, welcomed the budget’s focus on “embedded pharmacy positions in aged care, investment in equal access to new medicines and improvements to hospital infrastructure”.
Wednesday 03 Apr 2019
Pharmacy Daily Wednesday 3rd April 2019 t 1300 799 220 w www.pharmacydaily.com.au page 2
The eyes have it for Galderma
YESTERDAY Galderma hosted an event in Sydney to launch a new cosmetic surgery concept called WiF-EYE, based on the potential environmental factors such as digital screen use and exposure to blue light may contribute to the development of fine lines and wrinkles around the eyes.
Presenter Dr Juliana Sarubi (pictured) gave some background, with Galderma noting that its Dysport (clostridium botulinum type A toxin) is now available for the treatment of lateral canthal lines (crow’s feet) in Australia.
“The periorbital area, consisting of the eyelids and surrounding areas, is one of the first areas to show signs of ageing,” the company said, often due to repetitive contraction of the muscles around the eye area.
“Emerging concepts like Wif-EYE help us to investigate environmental factors that may contribute to premature ageing,” Sarubi noted.
This year 580,000 anti-wrinkle procedures are expected to be carried out in Australia, up 30% over the last four years.
More pregnancy training neededPHARMACISTS’ efforts to
improve pregnant women’s medication adherence are falling short due to a lack of access to reliable information, a group of international academics believe.
The meta-analysis of 14 studies reporting on women’s beliefs about medicines and adherence to pharmacotherapy during pregnancy published from 2000 onwards, found community pharmacists needed more training to improve adherence.
“Concerns about medication use and non-adherence are widespread among pregnant women,” the authors said.
“Women are more reluctant to use medicines during pregnancy and tend to overestimate the teratogenic risk of medicines.
“Risk perception varies with type of medicine, level of health literacy, education level and occupation.
Furthermore, low medication adherence during pregnancy is common, the paper concluded.
“Finally, limited evidence showed
current community pharmacists’ counselling is insufficient. Barriers hindering pharmacists are insufficient knowledge and limited access to reliable information.
“Further education, training and research are required to support community pharmacists in fulfilling all the opportunities they have when counselling pregnant women.”
Speak to your Apotex Territory Manager for launch deals
Apotex Pty Ltd, Macquarie Park NSW 2113, ABN 52 096 916 148. The APOTEX and Amplio trade marks are used under licence. Copyright © February 2019. All rights reserved. www.ampliovitamins.com.au PM-AU-1720
Formulated
by science for your pharmacypharmacy
New products
now available
Perx Health ramps upPERX Health and GuildLink are
expanding their patient medication management program.
Launched in 2018, the Perx program is offered to patients living with Parkinson’s Disease and provides free access to the Perx medication adherence app via Guildcare NG pharmacies.
The program has now expanded to include patients living with hypertension as well as transplant recipients taking specific medications.
Click on the Perx Health App advertisement on page one.
Advantage winnersWINNERS of the $100 to spend
in store in the Advantage loyalty competition came from Advantage Pharmacy Lobethal, Claremont Plaza Advantage, Convenient Chemist Wollongong, Craignish Pharmacy, Howles Pharmacy, Lang Lang Pharmacy, Lowood Advantage, Melton Pharmacy Superstore, Pharmacy 360 Black Rock and Woolgoolga Coastal Chemist.
Everyday this week Pharmacy Daily and PURE Papaya are giving away a prize pack valued at $48.95.100% Natural skin care range perfect for use by the whole family. PURE range includes Vapour Balm (Chest rub), Papaya Ointment (ultra-rich multi use skin food), Papaya Renew (Scars & Stretch marks), Papaya Lips (lip balm to nourish & protect). Visit Purepapayacare.com.au to find out more.To win, be the first from WA to send the correct answer to the question to [email protected]
Congratulations to yesterday’s winner, Bec Higgins.
Why is PURE Papaya Ointment effective for
irritated skin?
Wednesday 03 Apr 2019
Pharmacy Daily Wednesday 3rd April 2019 t 1300 799 220 w www.pharmacydaily.com.au page 3
business events news
EDITORIALEditor in Chief and Publisher – Bruce Piper Senior Journalist – Nicholas O’Donoghue Reporter – Mal SmithContributors – Jasmine O’Donoghue, Adam Bishop, Sarah Fairburn, Anastasia [email protected]
ADVERTISING AND MARKETINGSean Harrigan, Hoda Alzubaidi and Melanie [email protected]
BUSINESS MANAGERJenny Piper [email protected]
www.pharmacydaily.com.auPharmacy Daily is part of the Business Publishing Group family of publications.
Pharmacy Daily is Australia’s favourite pharmacy industry publication.
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Suite 1, Level 2, 64 Talavera Rd Macquarie Park NSW 2113 AustraliaPO Box 1010 Epping NSW 1710 AustraliaTel: 1300 799 220 (+61 2 8007 6760)
Sign up free at www.pharmacydaily.com.au
Welcome to our weekly promoted feature with all the latest health, beauty and new products for pharmacy.
Suppliers wanting to promote products in this feature should email [email protected]
Health, Beauty and New Products
SUBSCRIBE NOW
A new publication for travel and cruise
lovers
IN THE pharmacy business, most would assume sales of medicines and other healthcare products would cover the rent.
However, one Irish pharmacy has turned to crowdfunding service, Patreon, to raise the cash required to keep its doors open.
Established in 1853, with an interior to match, Sweney’s Pharmacy is a Dublin institution, featured in James Joyce’s epic Ulysses, due to the famous lemon-scented soap made by the proprietors for generations.
Over the past 10 years the pharmacy (pictured) has transitioned from an active dispensary into a volunteer-run museum of pharmacy, attracting visitors from around the world.
While the store hasn’t dispensed in a decade, the pharmacy was able to keep the landlord from the door through a combination of sales of the lemon soap and donations from visitors.
However, last Jul rent for the 11ft by 14ft pharmacy doubled to €1,500 ($2365) a month, forcing the volunteers to come up with some creative solutions to ensure the doors stay open.
Dispensary Corner
New MediChoice InhalerNova Pharmaceuticals brings its new MediChoice Inhaler to market with special introductory deals via Clear Sales Australia. This inhaler provides fast and temporary relief from nasal congestions, making breathing feel clear and cool. Packed in a convenient shelf spray of six, MediChoice Inhaler is the only alternative to the originator. Offering high pharmacy margins, and lower cost to your customers, MediChoice is the right choice this season. Available through DHL and API now.
Stockist: Clear Sales 1800 640 043RRP: $6.49Website: www.novapharm.com.au
Cheeki Stainless Steel StrawsChoose reusable Cheeki Stainless Steel Straws that don’t ‘suck’ for
the environment. These stainless steel straws have
been designed to last a lifetime and feature a
rounded mouthpiece with no sharp edges for the safest of sips. Keep a set of reusable straws in your bag or car and you’ll never need to resort to the single-use
kind again. Available in a variety of packs, straight and bent options in gorgeous metallic shades – silver, gold, black & rose gold. All straw packs come with a cleaning brush and the set of four straws also includes a fabric storage bag.
Stockist: 02 9981 1000RRP: $12.95 - $24.95Website: www.cheeki.net.au
Toothbrush Set: 3-StageThe Dreambaby 3-stage Baby Gum and Tooth Care Toothbrush Set suits babies who are teething. The three stage system follows dental development and ensures comfort in your little one’s mouth. Stage 1 brush: Soft rubber to gently massage sore or tender gums. Stage 2 brush: Very gentle rubber spikes, great for cleaning and massaging cavities, gums, tooth rim and growing baby teeth. Stage 3 brush: Soft bristles for developing teeth, ensuring comfort and great oral hygiene. The set is available in pink (pictured) and blue.
Stockist: 02 9386 4000RRP: $9.95Website: www.dreambaby.com.au
We Test: At-Home Urine TestTest your urine for 11 different parameters in the privacy of your own home with We Test’s At-Home Urine Test for Health. Instant results. A urine test for your health & wellbeing. Each test strip tests for 11 different parameters. Each parameter tests for different substances in the body. The colours on the strip change based on your urine: test for dehydration, glucose, protein, vitamin C, pH
levels, white blood cells, nitrite, keytones, bilirubin, urobilinogen and blood. Always read the label; use only as directed; if symptoms persist see your doctor.
Stockist: Major wholesalersRRP: $19.99Website: www.wetestonline.com
Copyright © MIMS Australia Pty Ltd Locked Bag 3000, St Leonards NSW 1590
T +61 2 9902 7700 F +61 2 9902 7701www.mims.com.au
ACN 050 695 157, ABN 68 050 695 157
April 2019
New Products
Telotristat ethyl (as telotristat etiprate) (Xermelo) and its active metabolite (telotristat) are inhibitors of L-tryptophan hydroxylases (TPH1 and TPH2), the rate limiting steps in serotonin biosynthesis. Serotonin regulates secretion, motility, inflammation and sensation of the gastrointestinal tract, and is over secreted in patients with carcinoid syndrome. Through inhibition of peripheral TPH1, telotristat reduces the production of serotonin, thus alleviating symptoms associated with carcinoid syndrome. Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. Xermelo tablets contain telotristat ethyl (as telotristat etiprate) 250 mg in a pack size of 90.
New Indications
Mepolizumab (rch) (Nucala) is now indicated as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA) in adults aged ≥ 18 years.
Morphine sulfate pentahydrate (Kapanol 10 mg, 20 mg) is now indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe chronic obstructive pulmonary disease (COPD), cardiac failure, malignancy or other cause. Kapanol should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and non-pharmacological treatments are not effective. Treatment with Kapanol in this setting should only be initiated by a specialist knowledgeable in its use.
Tofacitinib (Xeljanz) is now indicated for the treatment of adults with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy. Therapy with Xeljanz should be initiated and monitored by a specialist physician with expertise in the management of conditions for which Xeljanz is indicated (e.g. gastroenterologist).
New Contraindications
Amoxicillin (trihydrate)/clarithromycin/esomeprazole (magnesium trihydrate) (Nexium Hp7) contains clarithromycin, which is contraindicated with concurrent domperidone, hypokalaemia (risk of QT-time prolongation), severe hepatic failure in combination with renal impairment.
Hylan G-F 20 (Synvisc, Synvisc-One) should not be used in patients with known hypersensitivity (allergy) to hyaluronan (sodium hyaluronate) preparations.
Saxagliptin (hydrochloride)/metformin hydrochloride (Kombiglyze XR) is now contraindicated with acute or chronic metabolic acidosis, including lactic acidosis, with or without coma.
This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.
Related Documents
